• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传易感性与晚期糖基化终产物毒性相关,与慢性血液透析患者的预后相关。

Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.

机构信息

Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.

出版信息

Kidney Blood Press Res. 2010;33(1):30-6. doi: 10.1159/000285845. Epub 2010 Feb 23.

DOI:10.1159/000285845
PMID:20185929
Abstract

BACKGROUND

Advanced glycation end products (AGEs) belong to uremic toxins and some pathological effects of AGEs are linked to RAGE (receptor for AGEs). Their precursors are detoxified by the glyoxalase (GLO) system. The A419C (E111A) polymorphism of the GLO I gene is associated with vascular disease in hemodialysis (HD) patients and some RAGE gene polymorphisms are implicated in various pathological states.

AIM

To study the relationship of A419C GLO I and four RAGE polymorphisms (-429T/C, -374T/A, 2184A/G and Gly82Ser) in the prognosis of HD patients.

METHODS

The group studied consisted of 214 chronic HD patients prospectively followed up for 43 months. 100 patients died, 48 due to cardiovascular causes.

RESULTS

The Kaplan-Meier analysis showed a higher mortality rate in patient-mutated homozygotes for RAGE -429CC, RAGE 2184GG and GLO I 419CC. A higher hazard risk was confirmed by the Cox proportional hazards model when wild-type homozygotes were taken as reference: RAGE -429CC 2.28 (95% CI 1.04-4.99), RAGE 2184GG 3.16 (95% CI 1.44-6.93), and GLO I 419CC 1.75 (95% CI 1.08-2.86). Both RAGE polymorphisms were also associated with cardiovascular mortality: RAGE -429CC 3.54 (95% CI 1.37-9.14) and RAGE 2184GG 5.04 (95% CI 1.93-13.11).

CONCLUSION

In summary, our study shows for the first time a link between RAGE and GLO polymorphisms in the prognosis of HD patients.

摘要

背景

晚期糖基化终产物(AGEs)属于尿毒症毒素,AGEs 的一些病理作用与 RAGE(AGEs 受体)有关。其前体通过糖氧还蛋白(GLO)系统解毒。GLO I 基因的 A419C(E111A)多态性与血液透析(HD)患者的血管疾病有关,而一些 RAGE 基因多态性与各种病理状态有关。

目的

研究 GLO I 基因的 A419C 和 RAGE 基因的四个多态性(-429T/C、-374T/A、2184A/G 和 Gly82Ser)与 HD 患者预后的关系。

方法

本研究纳入 214 例前瞻性随访 43 个月的慢性 HD 患者。100 例患者死亡,其中 48 例死于心血管原因。

结果

Kaplan-Meier 分析显示,RAGE-429CC、RAGE-2184GG 和 GLO I-419CC 患者的突变纯合子死亡率较高。Cox 比例风险模型证实,当以野生型纯合子为参考时,风险比更高:RAGE-429CC 2.28(95%CI 1.04-4.99)、RAGE-2184GG 3.16(95%CI 1.44-6.93)和 GLO I-419CC 1.75(95%CI 1.08-2.86)。两种 RAGE 多态性也与心血管死亡率相关:RAGE-429CC 3.54(95%CI 1.37-9.14)和 RAGE-2184GG 5.04(95%CI 1.93-13.11)。

结论

总之,我们的研究首次表明,在 HD 患者的预后中,RAGE 和 GLO 多态性之间存在关联。

相似文献

1
Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.遗传易感性与晚期糖基化终产物毒性相关,与慢性血液透析患者的预后相关。
Kidney Blood Press Res. 2010;33(1):30-6. doi: 10.1159/000285845. Epub 2010 Feb 23.
2
Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.可溶性晚期糖基化终产物受体 (sRAGE) 以及 RAGE 和甘油醛 3-磷酸脱氢酶 I 基因多态性与胰腺癌患者的关系。
Clin Biochem. 2010 Jul;43(10-11):882-6. doi: 10.1016/j.clinbiochem.2010.04.004. Epub 2010 Apr 14.
3
A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients.乙二醛酶I基因的A419C(E111A)多态性与慢性血液透析患者的血管并发症
Ann N Y Acad Sci. 2008 Apr;1126:268-71. doi: 10.1196/annals.1433.012. Epub 2007 Dec 13.
4
Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.晚期糖基化终末产物受体——慢性血液透析患者的可溶性形式及基因多态性
Nephrol Dial Transplant. 2007 Jul;22(7):2020-6. doi: 10.1093/ndt/gfm050. Epub 2007 Mar 8.
5
Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.晚期糖基化终产物受体和乙二醛酶I在肾癌患者中的多态性
Tumour Biol. 2015 Mar;36(3):2121-6. doi: 10.1007/s13277-014-2821-0. Epub 2014 Nov 19.
6
RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation.肾移植术后12个月时的晚期糖基化终末产物受体基因多态性、肾功能及组织学检查结果
Clin Biochem. 2009 Mar;42(4-5):347-52. doi: 10.1016/j.clinbiochem.2008.12.006. Epub 2008 Dec 24.
7
The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.晚期糖基化终末产物受体基因(RAGE)的-429 T/C和-374 T/A基因多态性并非斯洛文尼亚2型糖尿病患者群体冠状动脉疾病的风险因素。
Coll Antropol. 2004 Dec;28(2):611-6.
8
Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.慢性疾病中的晚期糖基化终末产物——临床化学与遗传背景
Mutat Res. 2005 Nov 11;579(1-2):37-46. doi: 10.1016/j.mrfmmm.2005.03.024. Epub 2005 Aug 5.
9
Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.晚期糖基化终末产物的内源性分泌受体与终末期肾病中的心血管疾病
J Ren Nutr. 2008 Jan;18(1):76-82. doi: 10.1053/j.jrn.2007.10.016.
10
Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.晚期糖基化终末产物受体(RAGE)——乳腺癌患者中的可溶性形式(sRAGE)及基因多态性
Cancer Invest. 2007 Dec;25(8):720-5. doi: 10.1080/07357900701560521.

引用本文的文献

1
Association between variants and gestational diabetes mellitus susceptibility in a Chinese population: a preliminary study.中国人群中变异与妊娠糖尿病易感性的关联:一项初步研究。
Front Endocrinol (Lausanne). 2023 Nov 3;14:1235581. doi: 10.3389/fendo.2023.1235581. eCollection 2023.
2
The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy.衰老相关疾病中的甘油醛系统:营养干预作为抗衰老策略。
Cells. 2021 Jul 22;10(8):1852. doi: 10.3390/cells10081852.
3
Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study.
血浆中晚期糖基化终产物水平与 EPIC 研究中的结直肠癌风险。
Carcinogenesis. 2021 May 28;42(5):705-713. doi: 10.1093/carcin/bgab026.
4
Relationship between RAGE gene polymorphisms and cardiovascular disease prognosis in the Chinese Han population.中国汉族人群中RAGE基因多态性与心血管疾病预后的关系。
Mol Genet Genomics. 2017 Oct;292(5):1139-1149. doi: 10.1007/s00438-017-1341-1. Epub 2017 Jun 28.
5
Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.晚期糖基化终产物受体和乙二醛酶I在肾癌患者中的多态性
Tumour Biol. 2015 Mar;36(3):2121-6. doi: 10.1007/s13277-014-2821-0. Epub 2014 Nov 19.
6
Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression.甘醇醛酶 1-419C>A 变体与氧化应激相关:在前列腺癌进展中的意义。
PLoS One. 2013 Sep 10;8(9):e74014. doi: 10.1371/journal.pone.0074014. eCollection 2013.
7
Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.晚期糖基化终末产物在透析患者中的作用及潜在治疗干预措施
Semin Dial. 2012 Sep-Oct;25(5):529-38. doi: 10.1111/j.1525-139X.2012.01081.x. Epub 2012 Apr 30.